没有研究的可药化基因组的照明功能
Shawn M Gomez1, Alison D Axtman1, Timothy M Willson1
1University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Drug discovery today
|January 13, 2024
概括
研究人员创造了资源来研究未被研究的激酶,对细胞信号和疾病至关重要. 这些工具,包括类图书馆和化学探针,现在可用于推进暗酶研究.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类基因组包括500多种蛋白质激酶,这些激酶对于细胞信号传递至关重要,并与各种疾病有关.
- 这些激酶的很大一部分,大约三分之一,仍未得到充分研究,这阻碍了对它们的作用的全面理解.
研究的目的:
- 开发和提供新的资源,以深入研究研究不足的蛋白质激酶.
- 促进对目前缺乏广泛研究的激酶的功能和治疗向的研究.
主要方法:
- 创建一个重氨基酸库,用于定量蛋白激酶表达分析.
- 使用迷你Turbo-生物联酶标记用于靠近依赖的蛋白质生物化,以映射酶相互作用网络.
- 开发NanoBRET探针,用于评估活细胞测定中的化学工具目标特异性.
- 针对未研究的激酶的小分子抑制剂的表征.
- 计算工具的应用,以阐明基因组架构.
主要成果:
- 已经产生了一系列资源,包括定量测试,交互映射工具和活细胞查探针.
- 化学工具和计算框架已经开发和表征了研究不足的激酶.
- 黑暗激酶知识库已建立,以集中访问这些有价值的研究资产.
结论:
- 开发的资源显著提高了研究未得到充分研究的激酶的能力.
- 通过黑暗激酶知识库增加这些工具的可访问性将加速对激酶功能和疾病机制的研究.
- 这一倡议旨在阐明"暗酶"在生物过程和疾病状态中的作用.
关键词:
在NanoBRET中使用NanoBRET.肯定的数量/PRM化学工具 化学工具 是一种化学工具.暗酶知识库的基础知识库人类基因组的人类基因组照亮了可使用药物的基因组.miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo miniTurbo mini没有研究过的激酶.相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


